Paul Lee

Popular Topics

Intellectual Property

Paul Lee’s articles from Wiggin & Dana are most popular:

with readers working within the Pharmaceuticals & BioTech and Law Firm industries
within Intellectual Property topic(s)
in North America, United States and Asia

DETAILS

United States

+1 212 551 2600

AUTHORS CONTENT

Federal Circuit Affirms Invalidity Of Cancer Treatment Patents For Lack Of Enablement

United States IP

Skinny Labels, Big Stakes For Pharmaceuticals: The Supreme Court’s Hikma v. Amarin Decision

United States IP

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More